PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22963803-7	2012	Our results demonstrate how immunization with CNI-KLH produces large amounts of moderate affinity anti-nicotine antibodies even when formulated with ALUM adjuvant, making it particularly relevant for human use.	Nicotine	103-111	5'-nucleotidase, cytosolic IA	Homo sapiens	46-49	
22963803-10	2012	Vaccination with CNI, but not NIC, resulted in an increase of self-administration responding on a progressive ratio schedule using a high nicotine dose (0.03 mg/kg/infusion;   2 cigarettes in human) as compared to KLH-controls.	Nicotine	138-146	5'-nucleotidase, cytosolic IA	Homo sapiens	17-20	
22963803-11	2012	Furthermore, vaccination with CNI was able to antagonize the analgesic effects of a heavy bolus dose of nicotine (0.35 mg/kg).	Nicotine	104-112	5'-nucleotidase, cytosolic IA	Homo sapiens	30-33